Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141021 · ClinicalTrials.gov registry record
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
A clinical trial of Malignant Peripheral Nerve Sheath Tumors, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 1,050
- Enrollment target
- 13
- Study locations
NCT03141021: Recruiting study of Malignant Peripheral Nerve Sheath Tumors, sponsored by Washington University School of Medicine.
NCT03141021 is a study of Malignant Peripheral Nerve Sheath Tumors that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 1,050 participants, above the 460-participant average among 3 other Malignant Peripheral Nerve Sheath Tumors trials with a reported enrollment target (128% higher). The trial reports 13 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03141021, a study of Malignant Peripheral Nerve Sheath Tumors, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 1,050 participants
- Enrollment target
- 13
- Study locations
Study Summary
First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A worldwide database will be established, collecting, in a standardized manner, histologic, immunohistochemical, molecular, radiographic, treatment, and related clinical data from centers worldwide with expertise in these NF1-related cancers. Although retrospective in nature, the resulting data from this registry may reveal previously unanticipated patterns, similar to the INFACT effort outcome. This registry would then allow the acquisition of data associated with MPNST biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing data for aggregate analyses). Second, the investigators plan to co-register patients to institutional banks in order to prospectively collect MPNST samples for analysis. These patients will be consented in order to collect the above information and for banking of tumor tissue and future studies that include genomic characterization of the tumors.
Primary Outcome
-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST
Conditions Studied
Study Locations (13)
Maryland
- Johns Hopkins - Baltimore
- National Institutes of Health (NIH) - Bethesda
Other
- Global Gene Corporation - Mumbai
- Royal National Orthopedic Hospital - London
Florida
- Moffitt Cancer Center - Tampa
Massachusetts
- Dana Farber Cancer Institute - Boston
Minnesota
- University of Minnesota - Minneapolis
Missouri
- Washington University School of Medicine - St Louis
New York
- Memorial Sloan Kettering Cancer Center - New York
Rhode Island
- Lifespan - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2017-04-28 |
| Est. Completion | 2053-04-30 |
What NCT03141021 shows while recruiting
NCT03141021 is an observational study that tracks outcomes without assigning an intervention. Its 1,050 participants enrollment target places it among the larger protocols in the corpus, above the 460-participant average among 3 other Malignant Peripheral Nerve Sheath Tumors trials with a reported enrollment target (128% higher).
The record links to 1 condition, with Malignant Peripheral Nerve Sheath Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT03141021 lists 13 locations in 11 states (Maryland, Other, Florida).
Frequently Asked Questions
What is clinical trial NCT03141021 about?
NCT03141021 is a clinical study titled "Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors". First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A worldwide database will be established,...
What is the current status of trial NCT03141021?
This trial is currently recruiting. The enrollment target is 1,050 participants. The study started on 2017-04-28. Estimated completion is 2053-04-30.
What conditions does trial NCT03141021 study?
This clinical trial studies the following conditions: Malignant Peripheral Nerve Sheath Tumors.
Who is sponsoring clinical trial NCT03141021?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03141021 being conducted?
This trial has 13 study locations across Florida, Maryland, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Peripheral Nerve Sheath Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI